Fritcet 500 Injection is a sterile solution containing 500 mg of ceftriaxone, a broad-spectrum cephalosporin antibiotic. This medication is primarily used for the treatment of various bacterial infections, including those affecting the respiratory tract, urinary system, skin, and soft tissues, as well as for certain types of meningitis and septicemia. Its efficacy against a wide range of gram-positive and gram-negative bacteria makes it a preferred choice in hospital settings and for outpatient therapies.
Ceftriaxone works by interfering with the bacterial cell wall synthesis, leading to the lysis and death of the bacteria. Its pharmacokinetics allow for once or twice-daily dosing, providing convenience and improving patient compliance. Fritcet 500 Injection is typically administered via intramuscular or intravenous routes, and dosage may vary depending on the severity of the infection, the patient's age, weight, and kidney function.
While Fritcet 500 is effective in treating infections, it is important to be aware of potential side effects. Common reactions may include gastrointestinal disturbances such as nausea and diarrhea, local pain or swelling at the injection site, and allergic reactions like rash or itching. Serious adverse effects, although rare, can include anaphylaxis, liver enzyme elevations, or severe skin reactions. Patients should be monitored closely for any signs of these effects, particularly during the initial doses.